Alx Oncology Holdings (ALXO) Cash from Operations (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.75% |
| Dec 31, 2025 | -11.04% |
| Sep 30, 2025 | 26.97% |
| Jun 30, 2025 | 5.10% |
| Mar 31, 2025 | 23.04% |
| Dec 31, 2024 | -26.28% |
| Sep 30, 2024 | 4.48% |
| Jun 30, 2024 | 29.95% |
| Mar 31, 2024 | 4.42% |
| Dec 31, 2023 | -27.34% |
| Sep 30, 2023 | 1.74% |
| Jun 30, 2023 | -14.00% |
| Mar 31, 2023 | -34.58% |
| Dec 31, 2022 | 33.08% |
| Sep 30, 2022 | -81.69% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | -18.22% |
| Dec 31, 2021 | 29.64% |
| Sep 30, 2021 | -20.53% |
| Jun 30, 2021 | -301.60% |
| Mar 31, 2021 | 62.28% |
| Dec 31, 2020 | -42.60% |
| Sep 30, 2020 | -54.92% |
| Jun 30, 2020 | 31.24% |
| Mar 31, 2020 | -211.86% |
| Dec 31, 2019 | 9.79% |